Evaluate TGTX stock safety — financial health, volatility, institutional backing, and risk factors.

What are the risks of investing in TGTX? | Glauxie AI

Q: What are the risks of investing in TGTX?

TG Therapeutics, Inc. (TGTX) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Michael S. Weiss. TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune... Employees: 399.

Q: How much debt does TGTX have?

Review TGTX total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Q: Is TGTX a good long-term investment?

Evaluate TGTX as a long-term investment using fundamental scores, growth metrics, and risk assessment.

What are the risks of investing in TGTX?

🦉

TG Therapeutics, Inc. (TGTX)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOMichael S. Weiss

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered...

Key Executives

Name	Title
Adam Waldman	Chief Commercialization Officer
Jenna Bosco	Senior Vice President of Corporate Communications
Michael S. Weiss	Chairman, Chief Executive Officer & President
Sean A. Power	Chief Financial Officer, Corporate Secretary & Treasurer

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

TGTX Profile Financials

Is TGTX stock safe? How much debt does TGTX have? Is TGTX a good long-term investment?